Intralymphatic allergen immunotherapy against pollen allergy: A 3-year open follow-up study of 10 patients

Ann Allergy Asthma Immunol. 2018 Nov;121(5):626-627. doi: 10.1016/j.anai.2018.07.010. Epub 2018 Sep 13.

Authors

Lars Ahlbeck¹, Emelie Ahlberg², Ulla Nyström³, Janne Björkander⁴, Maria C Jenmalm²

Affiliations

¹ Allergy Center, University Hospital, Linköping, Sweden. Electronic address: lars.ahlbeck@regionostergotland.se.
² Unit of Autoimmunity and Immune Regulation, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
³ Allergy Center, University Hospital, Linköping, Sweden.
⁴ Futurum, Academy of Health and Care, Jönköping, Sweden.

PMID: 30021119
DOI: 10.1016/j.anai.2018.07.010

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Allergens / administration & dosage*
Allergens / adverse effects
Female
Follow-Up Studies
Humans
Immunotherapy / methods*
Injections, Intralymphatic
Male
Middle Aged
Pilot Projects
Pollen / immunology*
Rhinitis, Allergic, Seasonal / therapy*
Treatment Outcome
Young Adult

Substances

Allergens